全文获取类型
收费全文 | 827篇 |
免费 | 27篇 |
国内免费 | 17篇 |
专业分类
儿科学 | 9篇 |
妇产科学 | 48篇 |
基础医学 | 31篇 |
临床医学 | 46篇 |
内科学 | 83篇 |
神经病学 | 14篇 |
特种医学 | 21篇 |
外科学 | 193篇 |
综合类 | 100篇 |
预防医学 | 25篇 |
药学 | 91篇 |
中国医学 | 13篇 |
肿瘤学 | 197篇 |
出版年
2023年 | 8篇 |
2022年 | 9篇 |
2021年 | 21篇 |
2020年 | 16篇 |
2019年 | 20篇 |
2018年 | 25篇 |
2017年 | 14篇 |
2016年 | 19篇 |
2015年 | 20篇 |
2014年 | 51篇 |
2013年 | 35篇 |
2012年 | 37篇 |
2011年 | 49篇 |
2010年 | 42篇 |
2009年 | 45篇 |
2008年 | 44篇 |
2007年 | 58篇 |
2006年 | 38篇 |
2005年 | 45篇 |
2004年 | 34篇 |
2003年 | 38篇 |
2002年 | 13篇 |
2001年 | 17篇 |
2000年 | 16篇 |
1999年 | 22篇 |
1998年 | 13篇 |
1997年 | 12篇 |
1996年 | 16篇 |
1995年 | 12篇 |
1994年 | 12篇 |
1993年 | 7篇 |
1992年 | 11篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 4篇 |
1988年 | 5篇 |
1987年 | 4篇 |
1986年 | 3篇 |
1984年 | 6篇 |
1982年 | 6篇 |
1981年 | 1篇 |
1980年 | 2篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1975年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有871条查询结果,搜索用时 31 毫秒
21.
《American journal of surgery》2020,219(4):673-680
ObjectivesTo assess the impact of short and long term outcomes of diaphragm resection and repair in cyto-reductive surgery (CRS) and intra-peritoneal chemotherapy (IPC).Methods1230 consecutive CRS/IPC procedures were performed between 1996 and 2018 in Sydney, Australia. Among these, 652 underwent diaphragmatic intervention. The analysis was preformed according to histological subtype. First diaphragm interventions were compared to non-diaphragmatic CRS. Secondly, diaphragm resection was compared to diaphragm stripping. Overall survival and recurrence free survival was assessed based on histological diagnosis.ResultsThere were no differences between the resection and stripping groups for the colorectal cohort. For mesothelioma, increased incidences of pleural effusions in the resection group were noted (63% vs.28%, p = 0.017). In HAMNs, the resection group was associated with increased reoperations (42% vs. 15%, p = 0.03) and in hospital death (16.7% vs. 0.6%, p = 0.012). Resection in LAMNs were linked with increased transfusion requirements (9 vs. 6, p = 0.01), reoperation (39% vs. 23%, p = 0.05) and prolonged length of stay (34 days vs. 25 days, p = 0.02).There were no differences in overall survival and recurrence free survival in colorectal cancer. Median overall survival was decreased in mesothelioma by 20 months. In LAMNs the median survival was significantly decreased for the resection group. Similarly, the resection group had a 4-month earlier recurrence.ConclusionWe conclude that diaphragm interventions are an essential part of CRS. They are associated with increased perioperative morbidity. This morbidity is not attributable to whether the patient underwent diaphragm stripping or resection. However in mesothelioma and LAMNs, requiring diaphragm resection is likely to be an indicator for tumor aggression. 相似文献
22.
A Wirsching R Vonlanthen K Lehmann 《Annals of the Royal College of Surgeons of England》2014,96(7):e22-e23
Introduction
Mesh fixation with tacker systems is common in laparoscopic and open hernia repair. Complications due to absorbable tackers are rare and have not been described in the literature. However, we report a case of gallbladder erosion due to tacker dislocation.Methods
An open hernia repair was performed using an intraperitoneal onlay mesh for a recurrent parastomal hernia after two previous mesh repairs in a 67-year-old patient.Results
On postoperative day 2, the patient was reoperated because of a dislocated tacker that eroded and perforated the fundus region of the gallbladder. Putatively, tacker dislocation occurred owing to imbalanced traction forces. Initially, the mesh was fixed with absorbable tackers around the stoma on the right and transmuscular suture fixation was carried out on the left abdominal side. On revision surgery, tension forces to the right were therefore neutralised by additional transmuscular sutures on the right side.Conclusions
Absorbable tackers in open hernia repair provide a safe and effective mesh fixation if tension forces are carefully avoided. 相似文献23.
目的:观察TP方案化疗联合腹腔热疗与单纯静脉化疗治疗中晚期卵巢癌的疗效及毒副反应。方法:87例患者根据随机表随机分为对照组(45例)与观察组(42例)。对照组采用TP方案,即多西他赛75 mg/m2(d1)联合顺铂70 mg/m2(d1)静脉滴注,21 d为1个周期;观察组采用静脉滴注多西他赛75 mg/m2(d1)、腹腔灌注顺铂70 mg/m2(d1),灌注后行腹腔微波热疗,每周2次,21 d为1个周期。结果:对照组与观察组的总有效率分别为37.8%、64.3%(P=0.047)。治疗后,两组患者血清中糖类抗原125(CA125)较治疗前明显下降,且观察组患者下降的幅度明显高于对照组(P<0.001);毒副反应主要为肌肉酸痛及骨髓抑制。结论:TP方案联合腹腔热疗可明显提高中晚期卵巢癌的总有效率,且毒副反应未明显增加。 相似文献
24.
PURPOSE This prospective, blinded study was designed to assess intraperitoneal cytokine productions and their relationship to clinical presentations and systemic inflammatory markers in patients with inflammatory bowel disease.METHODS Fifty patients who required abdominal surgery for active inflammatory bowel disease (ulcerative colitis, 27; and Crohns disease, 23) were investigated. Interleukin-1, interleukin-6, and tumor necrosis factor- levels in intraperitoneal fluid (obtained by intraoperative lavage) and plasma were measured by enzyme-linked immunosorbent assay. To compare intraperitoneal cytokine productions between diseases with a different degree of inflammation, intraperitoneal cytokine measurement also was performed for patients who required surgery for colorectal cancer (n = 25) and acute appendicitis (n = 25).RESULTS The median intraperitoneal cytokine (interleukin-1, interleukin-6, and tumor necrosis factor-) levels were significantly higher in patients with inflammatory bowel disease than in patients with colorectal cancer and acute appendicitis. In patients with inflammatory bowel disease, intraperitoneal cytokine levels were significantly higher in patients with intraperitoneal sepsis (abscess/fistula) than in patients without intraperitoneal sepsis at laparotomy. Intraperitoneal cytokine levels did not correlate with type of disease (ulcerative colitis/Crohns disease), age, gender, duration of disease before surgery, preoperative medical treatment, and the extent or site of disease. There were no significant correlations between intraperitoneal cytokine levels and the following systemic inflammatory markers: plasma cytokine levels, white blood cell count, platelet count, erythrocyte sedimentation rate, and C-reactive protein levels. Postoperative intraperitoneal septic complications (anastomotic leak/abscess/enterocutaneous fistula) more frequently occurred in patients with higher intraperitoneal cytokine levels.CONCLUSIONS Intraperitoneal cytokine productions were greatly elevated in patients with inflammatory bowel disease, and their levels correlated with the presence of intraperitoneal sepsis at laparotomy and development of postoperative intraperitoneal septic complications. Intraperitoneal cytokine levels showed no correlations with systemic inflammatory markers. 相似文献
25.
Bristow RE Santillan A Salani R Diaz-Montes TP Giuntoli RL Meisner BC Armstrong DK Frick KD 《Gynecologic oncology》2007,106(3):476-481
OBJECTIVE: To evaluate the cost-effectiveness of intraperitoneal cisplatin and paclitaxel chemotherapy as front-line treatment for patients with Stage III epithelial ovarian cancer following optimal primary cytoreductive surgery. METHODS: Based on Gynecologic Oncology Group protocols #172 and #158, a decision analysis model was created to compare two treatment strategies for patients with optimal residual disease Stage III ovarian cancer: (1) inpatient intravenous paclitaxel (24 h) and intraperitoneal cisplatin plus outpatient intraperitoneal paclitaxel chemotherapy (IP/IV), and (2) outpatient intravenous paclitaxel (3 h) and carboplatin chemotherapy (IV/IV). The cost-effectiveness of each strategy was evaluated from the perspective of society. RESULTS: Cost-effectiveness analysis revealed that the strategy of IP/IV chemotherapy had an overall cost per patient of $39,861 and effectiveness of 5.16 QALYs compared to $18,822 and 4.59 QALYs for IV/IV chemotherapy. The IP/IV chemotherapy strategy was associated with an additional 0.56 QALYs at an incremental cost of $21,039. The incremental C/E ratio for IP/IV chemotherapy was $37,454/QALY. Inpatient treatment accounted for 43.2% of the cost of IP/IV chemotherapy. Sensitivity analysis testing confirmed the robustness of the model. CONCLUSIONS: In this model, IP/IV chemotherapy was associated with a modest extension in quality-adjusted survival time but was also more costly than IV/IV chemotherapy. On balance, the IP/IV strategy can be considered a good healthcare value. However, these data also suggest that efforts to reduce the cost of IP/IV chemotherapy, such as through development of an ambulatory regimen with equivalent therapeutic efficacy but an improved toxicity profile, would improve the overall value of this adjuvant treatment program. 相似文献
26.
Fung-Kee-Fung M Provencher D Rosen B Hoskins P Rambout L Oliver T Gotlieb W Covens A;IP Chemotherapy Working Group/Society of Gynecologic Oncologists of Canada 《Gynecologic oncology》2007,105(3):747-756
OBJECTIVES: To evaluate the role of intraperitoneal (IP) chemotherapy as part of primary treatment in patients with advanced ovarian cancer and to develop standards of care within the context of current clinical practice. METHODS: A multidisciplinary expert panel, convened to develop standards on the use of IP chemotherapy, searched the MEDLINE, EMBASE, and Cochrane Library databases up to December 2006 for randomized trials or published standards on the efficacy and/or delivery of IP chemotherapy. RESULTS: Eight randomized trials comparing IP chemotherapy versus intravenous (IV) chemotherapy were identified. Three trials reported statistically significant improvements in median survival of 8.0, 11.0, and 15.9 months with cisplatin-based IP chemotherapy. In one trial, the 15.9-month improvement in median overall survival (RR=0.75, 95% CI=0.58-0.97) represented a 25% reduction in the risk of death with IP chemotherapy. Severe adverse events and catheter-related complications were often dose limiting with IP chemotherapy. Using a consensus-based approach with a nationally representative panel, multidisciplinary care standards were developed to review medical and surgical criteria, the practice setting, volume requirements, and the institutional criteria required to safely deliver IP chemotherapy. CONCLUSION: The survival benefits with cisplatin-based IP chemotherapy may represent a significant improvement in the outlook for select patients with advanced ovarian cancer. The delivery of IP chemotherapy is more challenging than the IV route; however, severe adverse events and catheter-related complications may be offset through research defining the optimum treatment regimen, and the standardization of care. System-wide standards for the delivery of IP chemotherapy in Canada for patients with optimally debulked stage III ovarian cancer are offered. 相似文献
27.
射频热疗结合腹腔热灌注化疗治疗晚期卵巢癌的近期疗效观察 总被引:2,自引:0,他引:2
目的:评估射频热疗结合腹腔热灌注化疗对晚期卵巢癌的治疗效果,以探讨治疗方法。方法:将46例晚期卵巢癌患者随机分为射频热疗结合腹腔热灌注化疗组(热化疗组)24例和腹腔常温灌注化疗组(化疗组)22例。全部病人均行常规腹腔穿刺,无腹水者穿刺成功后直接灌注,有腹水者先引流干净腹水再行灌注。热化疗组注入已预热到45℃的生理盐水 顺铂并立即用SR-1000射频热疗机进行热疗,维持腹腔内温度在40.5~43℃、70~90m in;每周热灌注化疗1次,单纯热疗1次;共治疗2~3周。化疗组注入常温下的生理盐水 顺铂,每周1次,共治疗2~3次。观察患者治疗后疼痛症状改变、腹水控制情况及生活质量等,对比两组的治疗效果。结果:两组的腹水控制率、疼痛的缓解率、生活质量改善率分别为:热化疗组65%,71.4%,66.7%;化疗组25%,30.8%,27.3%。两组间各项指标均有显著差异,而两组间的化疗毒副作用无明显差别,热化疗组出现3例脂肪硬结。结论:腹腔热灌注化疗结合射频热疗治疗晚期卵巢癌的效果优于单纯腹腔化疗,值得临床推广应用。 相似文献
28.
29.
There have been great advances in the therapy of cancer and leukemia. However, there are still many neoplastic
diseases that are difficult to treat. For example, it is often difficult to find effective therapies for aggressive cancer and leukemia. An NF- B inhibitor named dehydroxymethylepoxyquinomicin (DHMEQ) was discovered in
2000. This compound was designed based on the structure of epoxyquinomicin isolated from a microorganism.
It was shown to be a specific inhibitor that directly binds to and inactivates NF- B components. Until now,
DHMEQ has been used by many scientists in the world to suppress animal models of cancer and inflammation.
Especially, it was shown to suppress difficult cancer models, such as hormone-insensitive breast cancer and
prostate cancer, cholangiocarcinoma, and multiple myeloma. No toxicity has been reported so far. DHMEQ
was administered via the intraperitoneal (IP) route in most of the animal experiments because of its simplicity.
In the course of developmental studies, it was found that IP administration never increased the blood concentration of DHMEQ because of the instability of DHMEQ in the blood. It is suggested that inflammatory cells in
the peritoneal cavity would be important for cancer progression, and that IP administration, itself, is important
for the effectiveness and safety of DHMEQ. In the present review, we describe mechanism of action, its in vivo
anticancer activity, and future clinical use of DHMEQ IP therapy. 相似文献
30.
Ya-Tao Jia Bao-Lei Shi Jie Zhang Ying-Yi Li Jiang Zhu 《World Journal of Clinical Cases》2022,10(9):2878-2882
BACKGROUNDDiphallia is a highly uncommon congenital urogenital abnormality and a few connected reports have been published. However, no case of intraabdominal heterotopic diphallus has been documented to date. In the present study, we present a rare case of intraperitoneal ectopic bipenis.CASE SUMMARYA 49-year-old man was hospitalized with the chief complaint of hydronephrosis of both kidneys, which was discovered three days earlier through regular physical examination performed using urological ultrasound without significant lumbar or abdominal pain or bladder irritation. Physical examination showed normal external penile development, bilateral testes located on the left side of the scrotum, and a fused epididymis. Urological plain and enhanced computed tomography suggested bilateral hydronephrosis, bilateral ureters opened to the left side of the bladder wall; an intrapelvic soft tissue shadow on the left side of the bladder was considered a germline malformation called bipenis (hidden penis in the abdominal cavity). Based on the urological plain and enhanced computed tomography results, a 49-year-old man was diagnosed with bipenis (one hidden in the abdominal cavity). Ectopic penile compression produced bilateral ureteral dilatation and hydronephrosis. The ectopic penis was amputated and partially removed during surgery, and bilateral ureteral replantation was successfully performed. At a 2-mo follow-up, the patient was very satisfied with the operation, there was no significant hydronephrosis in both kidneys, and urination and erectile function were normal.CONCLUSIONTo our knowledge, this is the first report of diphallia with an intraperitoneal ectopic penis. Computed tomography or magnetic resonance imaging can be used to assess the associated internal anomalies before surgery. Postoperative pathological findings are the gold standard for the diagnosis. 相似文献